Program Overview
This program equips participants with the knowledge and skills to apply Risk Management as a strategic quality assurance tool across pharmaceutical and life sciences operations. Anchored on ICH Q9 and ISO 31000 guidelines, the course covers essential tools such as FMEA, FTA, HACCP, and HAZOP, with practical applications in QA, QC, manufacturing, and R&D. Through real-life case studies—spanning cleaning validation, supplier qualification, and recall prevention—participants will gain insights into regulatory expectations, common pitfalls, and best practices. Interactive simulations and workshops reinforce hands-on learning, enabling participants to design robust risk control strategies, build effective risk registers, and integrate risk-based thinking into continuous improvement and Quality by Design (QbD) frameworks.
Features
- Apply ICH Q9 and ISO 31000 principles to identify, assess, and mitigate risks in quality systems.
- Select and implement appropriate risk management tools (FMEA, HACCP, HAZOP, etc.) in real-world scenarios.
- Design proactive risk control strategies to minimize failures, recalls, and compliance gaps.
- Integrate risk management into Quality by Design (QbD) and continuous improvement initiatives.
Target audiences
- Manufacturing and Operations Professionals
- Regulatory Affairs and Quality Assurance Teams
- R&D Professionals
- Supply Chain Professionals
Curriculum
- 5 Sections
- 23 Lessons
- 1 Day
- Quality by Design – Introduction & Paradigm Shift5
- Core Elements of QbD5
- Design of Experiments (DoE) in QbD4
- Applications Across Pharma Value Chain5
- Challenges & Implementation Barriers4
- 5.1Organizational challenges: cost, cultural resistance, lack of data, technical know-how
- 5.2Misconceptions: QbD is regulatory burden vs. QbD as business enabler
- 5.3Interactive Exercise: Group discussion on overcoming QbD adoption barriers in participants’ organizations
- 5.4Building a roadmap for sustainable QbD maturity.



